STENTIT
1 known investors
STENTiT develops the Resorbable Fibrillated Scaffold (RFS), a temporary, resorbable vascular support structure designed to restore blood flow and support the artery's natural healing in endovascular treatments. Its first target indication is below-the-knee chronic limb-threatening ischemia (CLTI).
BiotechHealthtechMedical Devices
Investors · 1
Frequently asked questions
- What does STENTIT do?
- STENTiT develops the Resorbable Fibrillated Scaffold (RFS), a temporary, resorbable vascular support structure designed to restore blood flow and support the artery's natural healing in endovascular treatments. Its first target indication is below-the-knee chronic limb-threatening ischemia (CLTI).
- Who are STENTIT's investors?
- STENTIT's investors include BOM.